Cardiothoracic & vascular anesthesia

Quality comparison of autotransfusion devices in cardiac surgery: a prospective observational cohort study

Can J AnaesthPublished Prospective observational cohort study

Authors' conclusion

Wash quality and processing speed differed between autotransfusion devices and processing sets.

Study context

Population
Adults undergoing cardiac surgery with autologous cell salvage15 excluded, incomplete data
Participants
130 adults
Exposure
Four autotransfusion devices and their processing sets
Outcome
Wash quality (removal ratios of heparin, potassium, PfHb, white blood cells (WBCs), platelets; reinfusion heparin and potassium concentrations) and processing speed (RBC recovery rate)
Methodological detailsquality improvement initiative, consecutive patients, Device settings per manufacturer recommendations for optimal wash quality
  • Quality improvement initiative
  • Consecutive patients
  • Device settings per manufacturer recommendations for optimal wash quality

Main finding

As reported in the abstract

Wash quality and processing speed
Heparin removal, all devices
> 99%
Potassium removal, all devices
> 95%
Platelet removal, all devices
> 94%
Plasma free hemoglobin (PfHb) removal, all devices
> 85%
Median [IQR] WBC removal ratio across processing sets (significant differences)
26 [19-33]% to 59 [42-68]%
Median [IQR] heparin reinfusion concentration across processing sets (significant differences), U·mL-1 processed red cells
0.09 [0.08-0.11] to 0.63 [0.55-0.70]
Median [IQR] red blood cell (RBC) recovery rate across processing sets (significant differences), mL RBC·min-1
8 [8-10] to 24 [22-25]

Observational data: associations, not effects.

Original publication

Quality comparison of autotransfusion devices in cardiac surgery: a prospective observational cohort study. Can J Anaesth. Published 4 February 2025. doi:10.1007/s12630-024-02893-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.